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Viruses commonly utilize the cellular trafficking machinery of polarized cells to effect viral export. Hepa-
tocytes are polarized in vivo, but most in vitro hepatocyte models are either nonpolarized or have morphology
unsuitable for the study of viral export. Here, we investigate the mechanisms of trafficking and export for the
hepadnaviruses hepatitis B virus (HBV) and duck hepatitis B virus (DHBV) in polarized hepatocyte-derived
cell lines and primary duck hepatocytes. DHBV export, but not replication, was dependent on the development
of hepatocyte polarity, with export significantly abrogated over time as primary hepatocytes lost polarity. Using
Transwell cultures of polarized N6 cells and adenovirus-based transduction, we observed that export of both
HBV and DHBV was vectorially regulated and predominantly basolateral. Monitoring of polarized N6 cells and
nonpolarized C11 cells during persistent, long-term DHBV infection demonstrated that newly synthesized
sphingolipid and virus displayed significant colocalization and fluorescence resonance energy transfer, imply-
ing cotransportation from the Golgi complex to the plasma membrane. Notably, 15% of virus was released
apically from polarized cells, corresponding to secretion into the bile duct in vivo, also in association with
sphingolipids. We conclude that DHBV and, probably, HBV are reliant upon hepatocyte polarity to be
efficiently exported and this export is in association with sphingolipid structures, possibly lipid rafts. This
study provides novel insights regarding the mechanisms of hepadnavirus trafficking in hepatocytes, with
potential relevance to pathogenesis and immune tolerance.
Hepatocytes are polarized epithelial cells with distinct apical
and basolateral domains facing the bile canaliculi and the he-
patic sinusoid, respectively. Tight junctions between cells form
a barrier between blood and bile. Direct apical transport of
synthesized proteins from the trans-Golgi network (TGN)
plays a minor role in hepatocytes and similarly in hepatocyte-
derived HepG2 cells (16, 39). Instead, proteins destined for the
apical membrane are usually transported to the basolateral
membrane and sorted in basolateral early endosomes, before
transport to the apical surface (21, 41). Sphingolipid sorting in
epithelial cells results in both apical and basolateral transport
by differentially regulated mechanisms (42).
The role of epithelial cell polarity in viral entry and export
has been extensively investigated for a broad number of patho-
gens, using cell culture models of columnar epithelia. These
studies point to cell-specific, virus-specific transportation
mechanisms that have a significant relationship with clinical
pathophysiology. Epstein-Barr virus, for example, is exported
nonvectorially in mucosal epithelial cells (30), correlating with
its local and systemic infection, while rotavirus infects intesti-
nal cells apically and is released via the same domain into the
gastrointestinal lumen, largely limiting its serious clinical ef-
fects to the gastrointestinal tract (9). Recently, we showed that
hepatitis A virus (HAV) was exported from the basolateral
domain of polarized hepatocytes (26), contrary to the expected
biliary export of the virus and in contrast to what was seen
previously in similar studies using enterocyte-derived cells (3),
demonstrating the importance of using relevant hepatocyte-
derived cell lines to study interactions for hepatotropic viruses.
Persistent hepatitis B virus (HBV) infection causes liver
cirrhosis and hepatocellular carcinoma. Hepadnaviruses, in-
cluding both HBV and duck hepatitis B virus (DHBV), share
many aspects of their replication and infectivity behavior: they
reproduce exclusively in hepatocytes, are assembled in the
Golgi complex, and are exported to reenter the bloodstream. It
is therefore probable that the virus is exported predominantly
via the basolateral domain for release into the viral sinusoid, as
markers of viral replication in hepatocytes correlate with
viremia. Localization of DHBV at the basolateral surface of
duck hepatocytes also suggests that the virus is exported from
this plasma membrane (6). It has also been suggested that
HBV budding is reliant on the host endosomal sorting complex
required for transport (ESCRT) machinery, which regulates
trafficking of cargo into vesicular bodies for transportation
through the cell (12), although this was in a nonhepatocyte,
nonhuman cell line and in a cell transfection and not infection
system. The mechanism by which hepatocytes transport hep-
adnaviruses and whether they vectorially sort viruses before
export are unknown.
HBV establishes persistent infection in hepatocytes, driven
from a nuclear pool of covalently closed circular DNA. Cul-
tured cell lines are generally refractory to HBV infection, but
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replication can be established in hepatocyte-derived lines via
transient or stable transfection or transduction with vectors.
High viral replication levels have been achieved with recent
models using novel dual-transfection systems (14). These mod-
els have revealed many details of hepadnavirus replication,
assembly, and release, but most hepatocyte-derived cell lines
are nonpolarized. Previously, we have developed an HepG2-
derived cell line (N6) that retains characteristic features of
polarized hepatocytes but displays the morphology of simple
columnar epithelia, allowing conventional studies of virus traf-
ficking and release (26). Here we have used N6 cells trans-
fected or transduced with HBV or DHBV to reveal the first
details of hepadnavirus trafficking and export in relevant po-
larized cells. Current hepatocyte culture models cannot be
infected with hepatitis B virus. We have therefore used DHBV
as a representative hepadnavirus in many of the experiments
described here, allowing us to examine the export of infectious
virions from physiologically relevant, polarized hepatocyte-de-
rived cell lines by subsequent titration of infectious virus on
primary duck hepatocytes (PDHs) in culture.
MATERIALS AND METHODS
Materials. Brefeldin A and human albumin were from Sigma-Aldrich: goat
anti-rabbit Alexa 488, goat anti-mouse Alexa 586, Alexa 568 holotransferrin,
BODIPY-TR-C5 ceramide complexed to bovine serum albumin, and TOTO-3
were from Molecular Probes. PCR was performed using iQ SYBR green Super-
mix (Bio-Rad) in a Bio-Rad iQ LightCycler apparatus and primers supplied by
Geneworks (Australia).
Cell lines. HepG2 subclones N6 and C11 (26) were maintained in minimal
essential medium with 1% penicillin and streptomycin, 1% glutamine, and 10%
fetal bovine serum. Cells were seeded onto (0.4-m-pore-size) 25-mm Transwell
collagen-coated inserts (Costar) and used 14 days later. N6 and C11 cells were
also used to establish the DHBV-infected cell lines DVP and DVNP, respec-
tively, using a strategy of transient transfection and short-term drug treatment to
eliminate nontransfected cells without necessarily selecting for stable transfec-
tion. A linear 1.3 genome length of DHBV was amplified from pUC119-DHBV
(kind gift from Ulla Protzer) using primers flanking the full 1.3-length viral
genome and ligated into pCI-Neo (New England BioLabs) before transforma-
tion in Escherichia coli. The resultant plasmid, pCI-Neo.DHBV, was transfected
into N6 and C11 cells using Lipofectamine (Invitrogen), and cells were treated
with 800 g/ml G418 for 10 days. Microcolonies of cells were trypsinized using
cloning cylinders and seeded into 96-well plates in G418-containing medium for
48 h, representing about five population doubling times with drug selection. Cells
were subsequently maintained and passaged every 14 days without G418 selec-
tion, and clones DVP and DVNP that maintained the morphology of N6 or C11
cells and exhibited persistent production of DHBV were selected.
Vectors and transduction. Defective adenovirus vectors allow the efficient
transduction of HepG2 cells with transient production of infectious DHBV or
HBV (27). Adenovirus vector containing green fluorescent protein (GFP) and
the DHBV genome (adeno-GFP-DHBV) and adeno-GFP-HBV were kindly
provided by Ulla Protzer (Germany) and Joe Torresi (Australia), respectively.
Transwell membrane-cultured N6 and C11 cells were transduced with 106 infec-
tious particles of adeno-GFP-HBV or adeno-GFP-DHBV via the basolateral
domain. Transwells were washed, and cells were incubated at 37°C until GFP
expression was first detectable by immunofluorescence microscopy.
Primary duck hepatocytes. Animal experimentation was approved by the Al-
fred Medical Research and Education Precinct Animal Ethics Committee.
DHBV-positive PDHs were obtained by infecting day-old Pekin-Aylesbury duck-
lings with DHBV (strain D16). Seven days later, duckling livers were collagenase
perfused as previously described (31). PDHs were maintained in Williams E
medium with 10 mM Tris, pH 7.6, 6 mM HEPES, 0.02% sodium bicarbonate, 1%
penicillin, 1% streptomycin, 1% glutamine, 0.02% glucose, 10 M hydrocorti-
sone 21-hemisuccinate, 0.01% insulin, and 1.5% dimethyl sulfoxide. Superna-
tants from adeno-GFP-DHBV-transduced or persistently infected cell lines were
applied to DHBV-negative PDHs in serial dilutions (1) to determine the infec-
tious virus titer. Cells were checked for GFP expression after 3 days to confirm
the absence of carryover adeno-GFP-DHBV particles. Coverslips were fixed
after 7 days. DHBV-positive foci were quantified by indirect immunofluores-
cence.
Quantitative PCR. Quantitative PCRs were performed using primers DHBV
03 (ACTAGAAAACCTCGTGGACT) and DHBV 04 (GGGAGAGGGGAGC
CCGCACG) or HBV PC1 (GGGAGGAGATTAGGTTAA) and HBV PC2
(GGCAAAAACGAGAGTAACTC) (15, 37).
Southern blotting. Briefly, cells were lysed by freeze-thaw 3 times in phos-
phate-buffered saline (PBS). Nuclei were pelleted out. Samples were treated with
DNase I to remove nonencapsidated chromosomal DNA. Proteinase K was used
to degrade capsid proteins and release viral DNA. Samples were sequentially
phenol and chloroform extracted, and viral DNA was ethanol precipitated over-
night. Samples were RNase treated and electrophoresed on a 1% agarose gel.
The gel was washed in 0.25 M HCl and then sequentially washed in buffers (1.5
M CaCl2, 0.5 M NaOH, followed by 1.5 M NaCl, 0.25 M NaOH). The DNA was
transferred to a positively charged nylon membrane by capillary transfer over-
night in SSC (1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate). The
membrane was baked at 120°C for 20 min and hybridized with a full-length
[32P]dCTP-labeled DNA probe (Perkin Elmer, Australia) using a random prim-
ing kit (Amersham). Hybridized blots were exposed to Hyperfilm-ER (Amer-
sham).
Western blotting. Intracellular protein analysis was performed for the detec-
tion of L and S proteins, which reside in the endoplasmic reticular membranes of
the cell. Cell lysate was fractionated to isolate the membrane fraction. Samples
were electrophoresed through a 13% SDS-polyacrylamide gel in a Mini-Protean
II apparatus (Bio-Rad). Proteins were transferred onto a Hybond-C nitrocellu-
lose membrane (Amersham) using a Trans-Blot semidry transfer cell (Bio-Rad).
Membranes were blocked in 3% skim milk powder in PBS, followed by probing
using mouse anti-DHBV pre-S primary antibody (1H1) in 1% skim milk powder
in PBS–Tween 20 for 60 min. Alexa 680 anti-mouse secondary antibody was
added, and membranes were visualized on an Odyssey fluorescence plate reader
(Li-Cor Biosciences).
Indirect immunofluorescence. Fixed cells were treated with 1H1 antibody and
rabbit anti-ZO-1 antibody and counterstained with Alexa 568 goat anti-mouse
and Alexa 488 goat anti-rabbit secondary antibodies; nuclei were stained with
TOTO-3.
Transferrin studies. DHBV-infected monolayers of PDHs and DVP and
DVNP cells were pulsed with 0.05 mg/ml Alexa 568-labeled transferrin at 4°C for
15 min and then warmed to 37°C for 2 h. Cells were then washed and cooled
rapidly to 18°C for 60 min to hold all endosomal and Golgi complex-related
traffic (32). Brefeldin A (1 g/ml) or vehicle (equivalent units ethanol) as a
no-drug control was added, and cells were further incubated at 18°C for 15 min.
Coverslips were collected at time zero, and the cells were warmed to 37°C.
Coverslips were collected and fixed in 4% paraformaldehyde with 1% Triton
X-100 for immunofluorescence.
Sphingomyelin studies. PDHs (DHBV infected) were cultured on coverslips,
incubated with 5 M BODIPY-TR-C5 ceramide for 30 min at 4°C, and rinsed in
ice-cold medium before incubation at 18°C for a further 30 min to hold all newly
manufactured sphingolipids at the Golgi complex. Five percent bovine serum
albumin (BSA) was added to the cells to capture any basolaterally appearing
sphingolipid. Brefeldin A at 1 g/ml or vehicle was added, and cells were further
incubated at 18°C for 15 min. Cells were then warmed rapidly to 37°C to release
Golgi complex traffic, coverslips were collected at 0 and 30 min and fixed with
paraformaldehyde, and viral antigen was visualized with 1H1 and Alexa 488 goat
anti-mouse antibodies.
Microscopy. We used a Zeiss LSM 510 META microscope with a 60 oil-
immersion objective lens. Fluorescence resonance energy transfer (FRET) im-
ages between Alexa 488 and Alexa 568 were obtained by excitation at 488 nm
with an HFT 488-nm dichroic mirror and an LP 560-nm emission filter. In this
pair, 488-nm-stimulated molecules (donor) emit sufficient light to excite a mol-
ecule at 568 nm (acceptor), which will in turn emit light in the 568-nm spec-
trum. To ensure that we minimized any bleed-through effect, we analyzed images
in the 610-nm emission spectrum. Additionally, single-stained control images
were taken to confirm minimal bleed through. Raw images were analyzed with
the ImageJ program. Images were processed with Adobe Photoshop software.
Statistical analysis. Mean values with standard errors of the means are given.
Significance of differences was determined by unpaired two-tailed Student’s t
test. We accepted values of P of 0.05 to be significant.
RESULTS
Virus export is both dependent on cell polarity and vecto-
rial. We have observed that a significant proportion of primary
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duck hepatocytes (PDHs) will reestablish polarity for a vari-
able time in culture following preparation by collagenase per-
fusion. We examined the distribution of virus and ZO-1 as a
marker of cell polarity in clusters of congenitally DHBV-in-
fected PDHs in culture. Figure 1A shows a primary hepatocyte
couplet in culture demonstrating the formation of the apical
surface (bile ductule) and tight junction contact points be-
tween cells. Figure 1B shows a hepatocyte cell cluster with
evidence of early development of polarity in the center, dem-
onstrated by extensive tight junction formation (ZO-1), while
peripheral cells have not established polarity due to a lack of
cell contacts at the edge. Congenital DHBV infection leads to
ubiquitous infection throughout the liver, but the nonpolarized
peripheral cells show considerably more staining for virus-
specific antigen than the central, polarized cells. In contrast,
Fig. 1C shows a cluster of infected PDHs without evidence of
cell polarity and DHBV staining in all cells, suggesting that the
position in the cluster and intercellular contacts per se do not
inhibit viral replication. From these observations, we postu-
lated that polarized hepatocytes may export virus efficiently,
while nonpolarized cells retain virus.
We investigated the kinetic relationship between cell polar-
ity and export of infectious virus from DHBV-infected PDHs
over 30 days in culture (Fig. 2). Intracellular virus was present
at high levels on days 1 to 6, but exported virus was not
detected until day 9 (Fig. 2A). From days 12 to 18, the level of
virus export increased dramatically, accompanied by a decline
in intracellular virus. This period coincides with development
of polarity in the PDH culture, demonstrated by extensive tight
junction formation (Fig. 2B). At 18 days, the total amount of
infectious virus recovered from the culture was somewhat re-
duced, but the large majority of this was still exported from the
cells, which remained polarized, as demonstrated by ongoing
vectorial export of albumin. From 24 days, polarity was pro-
gressively lost, with a coincident decline in viral export and a
proportional increase in intracellular virus and with high yields
of infectious virus almost exclusively retained within the cells at
30 days. These data strongly suggested that in primary infected
hepatocytes, establishment and maintenance of cell polarity
were associated with efficient export of DHBV.
PDHs do not establish continuous cell monolayers in Trans-
well inserts. In contrast, N6 cells can be successfully grown in
this manner, and the vectorial export of albumin at their ba-
solateral domain provides a functional measurement of cell
polarity (26). N6 cells were transduced with adeno-GFP-
DHBV at 6 days after seeding, and supernatant and cell lysates
were examined for infectious virus over 30 days postransduc-
tion (Fig. 2C). By day 12 (6 days postransduction), cells were
highly polarized and also showed high levels of viral export,
with minimal accumulation of intracellular virus. The degree of
cell polarity and virus export declined thereafter, with progeny
virus almost exclusively retained within the cells by day 30,
supporting the strong relationship between cell polarity and
the efficiency of DHBV export seen in PDHs.
We then examined vectorial release of virus from polarized
and nonpolarized cells transduced with adeno-GFP-DHBV or
with adeno-GFP-HBV. Polarized N6 cells exported more than
75% of progeny HBV (measured by real-time PCR) and in-
fectious DHBV into the basolateral domain, whereas equal
proportions were exported from nonpolarized cells to the api-
cal and basolateral compartments of the Transwell apparatus
(Fig. 3A).
Hepatocyte export pathways. We disrupted intracellular he-
patocyte transport routes to map viral export pathways in
hepatocytes. Infected primary hepatocytes were treated with
brefeldin A, and replicate 6-h collections of supernatant were
collected before and after drug treatment and analyzed by
real-time PCR. Brefeldin A treatment of infected PDHs re-
sulted in a marked (2.5-fold) reduction of total virus export,
FIG. 1. DHBV export is dependent on cell polarity in primary
hepatocytes. Primary duck hepatocytes were prepared from a duck-
ling congenitally infected with DHBV and cultured for 6 days.
(A) A polarized couplet of hepatocytes in culture forms apical
surfaces with tight junctions, resembling a bile ductule (arrow).
Green, DHBV; red, nuclei. (B and C) Colonies may be polarized
(B), showing differential intracellular viral staining (red) between
central polarized cells (ZO-1, green) and peripheral nonpolarized
cells, suggesting preferential viral export from polarized cells. In
contrast, nonpolarized colonies (C) show no ZO-1 staining and
marked intracellular virus accumulation.
FIG. 2. Kinetics of infectious viral export. (A) Congenitally in-
fected PDHs were cultured for 30 days. Viral export (squares) signif-
icantly increased after day 12 as intracellular virus levels (circles) fell.
After day 27, virus was retained intracellularly as export fell. (B) Viral
secretion correlates with formation of tight junctions (ZO-1) and their
subsequent loss (day 30). (C) In adeno-DHBV-transduced polarized
N6 cells, declining functional polarity determined by vectorial albumin
transport (squares) was associated with a significant reduction in viral
export (crosses) and a corresponding increase in intracellular virus
accumulation (triangles).
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suggesting that active Golgi complex and endosomal viral
transport are required for efficient hepadnaviral release from
primary liver cells (Fig. 3B).
We noted above (Fig. 3A) that while the majority of virus
export from polarized HepG2 cells was basolateral, a small
proportion of the virus (about 12%) was released at the apical
domain. Interestingly, when we applied brefeldin A to polar-
ized HepG2 N6 Transwell cultures that had been transduced
with adeno-HBV (multiplicity of infection, 1), there was a
significant increase in the proportion of virus exported to the
basolateral domain, from 78% to over 90% (P  0.023) (Fig.
3C). As brefeldin A disrupts the Golgi complex and inhibits
TGN-related sorting (5, 35), these data suggest that while most
substrates are preferentially transported by Golgi complex-
dependent and Golgi complex-independent means to the ba-
solateral surface in hepatocytes (Fig. 3C), active sorting via a
brefeldin A-sensitive pathway directs some virus to the apical
surface.
Development of persistently infected cells. In order to more
closely model viral trafficking within polarized hepatocytes per-
sistently infected with hepadnaviruses, we developed DVP and
DVNP cells, which are polarized N6 and nonpolarized C11
cells, respectively, persistently infected with DHBV but with-
out the adenoviral vector, which interferes with cell integrity
over the course of longer experiments. In these DVP and
DVNP cells, DHBV production was established by transient
transfection and short-term G418 treatment to eliminate non-
transfected cells, but without long-term drug treatment to se-
lect stably transfected cells. Both cell lines secreted high titers
of DHBV, peaking at over 5  108 copies/ml/day from DVP
and over 2  108 copies/ml/day from DVNP, detected using
real-time PCR, with 10-fold lower titers of infectious virus
being detected by infection of PDHs. These lines retained the
polarity of the parent cells, with DVP cells showing apical
ZO-1 staining in a honeycomb pattern (Fig. 4A), vectorial
albumin export to the basolateral domain, and virus export
basolaterally (Fig. 4B), while the DVNP cells showed no or-
ganized ZO-1 staining and exported albumin equally to both
apical and basolateral Transwell compartments. DVP cell ly-
sate contained double-stranded and single-stranded DHBV
DNA (Fig. 4C). Western blot of lysates shows production of
viral L and S proteins (Fig. 4D), confirming that intracellular
viral replication of DHBV is occurring through viral replicative
intermediates and via viral protein production.
Virus traffic is independent of transcytosis. Hepatocytes
manufacture vast quantities of substrates which are exported
from the cell, predominantly into the sinusoid via the basolat-
eral domain. Synthesized protein is transported directly to the
basolateral domain, with any apically directed molecules then
subsequently transcytosing to the apical membrane (23). Like
other epithelial cells, they also transcytose extracellular pro-
teins. Unique among epithelial cells, hepatocytes both transcy-
tose transferrin from the extracellular environment and syn-
thesize it de novo. The bulk of the transcytosed transferrin
returns to the basolateral plasma membrane, but a small, slow
pathway has been shown to take some of it to the apical surface
in HepG2 cells (38). The well-defined transferrin transcytosis
pathway intersects with its biosynthetic pathway at the TGN (4,
28). PDHs and DVP cells (both of which are polarized) and
DVNP cells (nonpolarized) were pulsed with Alexa 568-la-
beled transferrin and examined by confocal microscopy. At
37°C, colocalization of transferrin and DHBV was significantly
higher in nonpolarized cells than polarized cells (Fig. 5). Inhi-
bition of transport from the Golgi complex with brefeldin A
resulted in perinuclear Golgi complex localization of both virus
and transferrin (Fig. 5A, parts B, D, and F). These data imply
that transferrin and DHBV share only a part of the transpor-
tation pathways in the hepatocyte and that this differential
transportation is polarity dependent.
Hepatocytes export DHBV with sphingomyelin. Sphingomy-
elin and glucosylceramide are synthesized from ceramide in
the Golgi complex. Sphingomyelin is transported to the baso-
lateral cell surface, while glucosylceramide is transported first
to the apical surface before transcytosis (22). These sphingo-
lipids are associated with rafts and trafficking in polarized cells,
including hepatocytes (8, 21, 25). As we had observed that a
proportion of DHBV was directly released at the apical do-
main (Fig. 3A and C), the association of sphingolipids with
viral transport was investigated.
In the Golgi complex of HepG2 cells, labeled ceramide
forms labeled sphingomyelin and glucosylceramide, which are
vectorially transported to the plasma membrane (21, 32–34,
42). Infected PDHs were pulsed with labeled ceramide and
stained for virus as described above, with BSA added to the
medium to capture exported sphingolipids and prevent recy-
cling. There was marked colocalization of sphingolipid and
viral envelope antigen in primary hepatocytes (Fig. 6A). Virus
FIG. 3. Viral traffic in hepatocytes. (A) N6 cells (black) grown on
membranes and transduced with adeno-GFP-HBV or adeno-GFP-
DHBV demonstrate vectorial export of both albumin and virus pre-
dominantly to the basolateral domain, while C11 cells (gray) show
nonvectorial secretion. Nonpolarized cells secreted albumin and virus
nonvectorially. (B) Viral traffic is dependent on the TGN and endo-
somal system. Treatment (black) with brefeldin A to disrupt the ve-
sicular transport system results in a marked reduction in total virus
export from PDHs (pretreatment, gray), whereas export is maintained
at constant levels during mock treatment (No Drug). *, P  0.05.
(C) Apical transportation of virus from the Golgi complex. Brefeldin A
treatment resulted in an increase in viral export to the basolateral
domain, implying a preferential inhibition of apical transportation with
brefeldin A.
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and sphingolipid remained colocalized at the Golgi complex in
the presence of brefeldin A, suggesting cotransportation and
shared mechanisms of sorting and trafficking.
We further investigated the colocalization of sphingolipid
and hepadnavirus by analyzing FRET between these molecules
in primary hepatocytes. Figure 6B shows high-signal FRET
between labeled sphingolipid and virus in primary hepatocytes.
DVP and DVNP cells pulsed with BODIPY-TR-C5 ceramide
showed synthesized sphingolipid and DHBV colocalized and
demonstrated a FRET signal regardless of cell polarity. Pho-
tobleaching of acceptor molecules showed marked donor flu-
orescence recovery, confirming FRET interaction between
DHBV and sphingolipid (Fig. 7). These data strongly suggest
that progeny hepadnaviruses and endogenous sphingolipid are
cotrafficked in hepatocytes, resulting in predominant basolat-
eral release but with significant levels of direct apical release.
DISCUSSION
Hepatocyte polarity is intrinsic to the synthetic and meta-
bolic functions of the liver. The formation of plasma mem-
brane polarity is influenced by the asymmetric distribution of
post-Golgi complex transport proteins, implicating a funda-
mental relationship between Golgi complex transport and
membrane polarity formation (10, 36). Studies of HAV in the
N6 cell line revealed unexpected basolateral export of this
enterically transmitted virus (26), underscoring the importance
of using polarized hepatocyte-derived cells to study trafficking
of hepatotropic viruses. Conversely, HBsAg has been used as a
protein to model cell-specific mechanisms of vectorial sorting
(18), but the apical sorting of HBsAg observed in MDCK
(canine kidney) cells is unlikely to be relevant to HBV repli-
cation in the liver since massive quantities of HBsAg are found
in the plasma, reflecting predominant basolateral sorting in
hepatocytes, as we have observed here and previously with
HAV (26).
Hepatitis B virus, along with other hepadnaviruses, is non-
cytopathic and strictly hepatotropic. The small viral genome
requires that it utilize cellular machinery for many of its func-
tions, a factor that contributes to its exclusive hepatotropism. It
is known that viral envelope proteins are assembled and mod-
ified in the endoplasmic reticulum (ER) and associate with the
genome-containing core on passage through the ER-Golgi
complex before export (13). Additionally, HBV export path-
ways that involve regulated endosomal structures and even
some that are independent of the endosomal machinery have
FIG. 4. Cell lines persistently infected with DHBV. (A) (i) DVP and DVNP cells express DHBV surface antigen (red), but the ZO-1 (green)
distribution indicates that only DVP cells are polarized. Bar, 5 m. (ii) When grown on membranes, DVP cells export a much greater percentage
(almost 100%) of the total virus (black bars) produced basolaterally than the nonpolarized DVNP cells, which parallels polarized albumin secretion
(gray bars). (B) These cell lines export virus efficiently (ii) with low intracellular levels (i) until 24 days of culture. (C) (i) Southern blotting of lysates
shows that the cell lines produce all intracellular DHBV viral replicative DNA intermediates: relaxed circular (RC), double-stranded (DS), and
single-stranded (SS) DNA. (ii) Western blotting shows both L and S antigens in lysates.
12478 BHAT ET AL. J. VIROL.
 o
n
 June 17, 2016 by Australian National Univ.
http://jvi.asm.org/
D
ow
nloaded from
 
been described, albeit in nonpolarized hepatocyte models (2,
12). The trafficking and export of hepatitis C virus and its core
protein have been shown to depend on endosomal structures in
HuH7 hepatocyte-derived cells (11). The export mechanisms
for hepadnaviruses in physiologically relevant, polarized hep-
atocyte-derived cells have not been previously addressed. Here
we have predominantly used DHBV to model HBV egress so
that we could utilize a primary cell culture model where pos-
sible, especially to examine viral trafficking and infectivity.
We observed that cell polarity was necessary for the efficient
export of DHBV from primary hepatocytes but was not re-
quired for viral replication, as evidenced by intracellular accu-
mulation of infectious particles over time with diminishing cell
polarity (Fig. 2). This was also seen in persistently infected
human hepatocyte-derived cells, which maintained a steady
rate of virus excretion for between 18 and 30 days in culture
but demonstrated a more than 10,000-fold increase in intra-
cellular virus during that time. Since the export pathways of
adenovirus-transduced HBV and DHBV were the same (Fig.
3), it is likely that HBV export is also vectorial. Such depen-
dence on cell polarity for virus export has significant implica-
tions for pathogenesis. Loss of cell polarity is characteristic of
cholestatic liver disease, and recent studies have also demon-
strated that hepatitis C virus (HCV) can directly down-modu-
late hepatocyte polarity (19). It is therefore likely that choles-
tasis and/or HCV coinfection could lead to increased
intracellular retention of progeny HBV and viral antigen and,
thus, increased pathological consequences.
The observed predominance of basolateral viral export is not
surprising and is consistent with the default pathway for export
of most substrates from hepatocytes, allowing direct export of
infectious virus into the bloodstream. Indeed, we have previ-
ously shown that hepatitis A virus is almost exclusively ex-
ported from hepatocytes via the basolateral domain (26), even
though its enteric transmission requires that HAV eventually
be released into the bile and feces. Surprisingly, we observed
apical release for a significant proportion of progeny DHBV
FIG. 5. Virus traffics with transferrin in polarized hepatocytes. (A) DHBV-infected polarized PDHs (parts A and B) and DVP cells (parts C
and D) and nonpolarized DVNP cells (parts E and F) were exposed to exogenous transferrin (red). There is minimal colocalization of transferrin
and virus throughout the cytoplasm in both hepatocytes and DVP cells (parts A and C) compared to nonpolarized cells (part E). Brefeldin A
treatment resulted in Golgi complex localization of transferrin and virus, regardless of polarity (parts B, D, and E). Bar, 5 m. (B) Colocalization
was quantified over each field in treated and untreated cells. Averages of at least nine fields over 3 experiments are given.
FIG. 6. DHBV colocalizes with sphingolipid. (A) DHBV-infected
PDHs were pulsed with BODIPY-TR-C5 ceramide, fixed, and stained.
DHBV (green) colocalized with all species of sphingolipid (red), which
persists with brefeldin A treatment. Sphingolipid accumulation in bile
ducts (small arrows) and in lipid vacuoles (large arrows) can be seen.
(B) Infected polarized PDHs and DVP cells and nonpolarized DVNP
cells show ubiquitous virus-lipid colocalization. FRET between virus
and newly synthesized sphingolipid is marked in both polarized and
nonpolarized cells. The pixel intensity along a line through the colo-
calized regions (orange) is shown in the graphs on the right. Blue,
nuclei and TOTO-3. Bar, 5 m.
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from polarized N6 or DVP cells, which would be consistent
with excretion of virus and antigen in bile. If this observation is
also true of HBV, then it is interesting to note that the anti-
genicity of HBsAg has been shown to be preserved in the
gastrointestinal tract (29). Although it appears to be unlikely
that the infectious enveloped DHBV (or HBV) would survive
exposure to bile salts, excretion of large amounts of viral an-
tigen into bile and the enterohepatic circulation could have a
significant role in promoting the development of immunolog-
ical tolerance to HBV.
The transferrin trafficking pathway in hepatocytes is distinct
from its pathway in other cells. In HepG2 cells, it has been
elegantly shown to follow entry and bulk-flow traffic to the
subapical compartment for sorting and recycling to the baso-
lateral membrane (4, 40). In this study, although virus and
transferrin colocalized in nonpolarized cells, DHBV did not
appear to traffic with transferrin when the transportation of the
two substrates was vectorially regulated, implying a differential
transportation system, albeit one still dependent on cell polarity.
Sphingolipid trafficking in polarized hepatocytes is distinct
from protein trafficking and is differentially regulated (7, 40),
but it is also polarity dependent (7, 33). We saw a close physical
association between sphingolipid and virus in hepatocytes,
strongly implying a cotransportation mechanism. The nature of
this virus-sphingolipid interaction remains conjecture. Envel-
oped viruses, being coated with lipoproteins, lend themselves
to transport by sphingolipid rafts, as has been suggested for
measles virus and HIV (17, 22, 24, 38). Additionally, the be-
havior of DHBV export from nonpolarized cells is consistent
with the behavior of raft-dependent sorting, described to be
similar in both polarized and nonpolarized hepatocytes (21).
We note that the antibody that we used to identify DHBV
will not distinguish between subviral particles, which have
identical envelope protein compositions (containing both S
and L proteins). As such, we cannot exclude the possibility that
the results of our colocalization studies reflect the fate of the
excess of subviral particles rather than the minor proportion of
intact virions; however, we believe that it is unlikely that these
particles have different pathways. While it has been suggested
that subviral particles in nonhepatocyte (MDCK) cells traffic
by different routes to HBV particles (18), this would appear to
be a function of the cells rather than the antigen because it is
contrary to the mass export of both HBsAg and HBV virions
into plasma from hepatocytes. In hepatocytes, synthesized
DHBV and subviral particles have been shown to enter the
same type of vesicular bodies after the endoplasmic reticulum
(20), which reinforces the need to use hepatocyte-derived cells
for the current studies.
It has been presumed that viruses, particularly noncyto-
pathic viruses such as DHBV and HBV, hitch a ride on pre-
existing cellular mechanisms for transport within the cell and
export from the cell. The determinants of this interaction,
however, had not been studied. It is possible that similar sph-
ingolipid-associated mechanisms may be utilized by other
hepatotropic viruses, including hepatitis C virus. The findings
of this study broaden our understanding of the mechanisms of
pathogen export from hepatocytes.
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